allopurinol sodium

Allopurinol Sodium is a xanthine oxidase inhibitor with an IC50 of 7.82±0.12 μM.

Allopurinol-[13C3] (Standard) is a reference standard of Allopurinol-[13C3] intended for quantitative analysis, quality control, and related biochemical research applications.

Allopurinol (Zyloric) is a Xanthine Oxidase Inhibitor. The mechanism of action of allopurinol is as a Xanthine Oxidase Inhibitor.

Allopurinol-D2 is a deuterated compound of Allopurinol. Allopurinol (T0692) has a CAS number of 315-30-0. Allopurinol (T0692) is a Xanthine Oxidase Inhibitor. The mechanism of action of allopurinol is as a Xanthine Oxidase Inhibitor.

Allopurinol (Standard) is the standard substance of Allopurinol, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Allopurinol (Standard) is a xanthine oxidase inhibitor and is therefore used in enzymology and purine metabolism research systems to investigate uric acid production pathways, oxidative stress linked to xanthine oxidase activity, and enzyme inhibition kinetics.

Allopurinol-13C,15N2 is an isotopically labeled form of Allopurinol (T0692) with Carbon-13 and Nitrogen-15. Allopurinol (T0692) is an effective oral xanthine oxidase inhibitor with an IC50 value range of 0.2-50 μM, used in the study of hyperuricemia and gout. It reduces the expression of HIF-1α and HIF-2α proteins and exhibits antidepressant and antinociceptive properties. Additionally, Allopurinol (T0692) has anti-leishmanial effects.